farnesol has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anupriya, K; Pabitha, R; Santhanasabapathy, R; Sudhandiran, G; Vasudevan, S | 1 |
| Bottiglieri, T; Chin, PC; D'Mello, SR; Liu, L; Morrison, BE; Ratan, RR; Siddiq, A | 1 |
2 other study(ies) available for farnesol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Farnesol quells oxidative stress, reactive gliosis and inflammation during acrylamide-induced neurotoxicity: Behavioral and biochemical evidence.
Topics: Acrylamide; Animals; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Farnesol; Gliosis; Hippocampus; Interleukin-1beta; Lipid Peroxidation; Male; Mice; Movement Disorders; Neurodegenerative Diseases; Neuroimmunomodulation; Neuroprotective Agents; Oxidative Stress; Tumor Necrosis Factor-alpha | 2015 |
The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism.
Topics: Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Huntington Disease; Indoles; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Phenols; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Salicylates; Signal Transduction | 2004 |